{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:21:52Z","timestamp":1767990112612,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T00:00:00Z","timestamp":1433289600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s13277-015-3616-7","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T18:59:01Z","timestamp":1433271541000},"page":"8559-8571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma)"],"prefix":"10.1007","volume":"36","author":[{"given":"Katarzyna","family":"Starska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Bry\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Forma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurek","family":"Olszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Pietkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Lewy-Trenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Stasikowska-Kanicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Danilewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Krze\u015blak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,3]]},"reference":[{"key":"3616_CR1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/SCS.0000000000000560","volume":"25","author":"FM Gu","year":"2014","unstructured":"Gu FM, Zhang LS. Clinical outcomes of endoscopic and open resection of recurrent sinonasal inverted papilloma. J Craniofac Surg. 2014;25:1090\u20133.","journal-title":"J Craniofac Surg"},{"key":"3616_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2500\/ajra.2012.26.3732","volume":"26","author":"JW Wood","year":"2012","unstructured":"Wood JW, Casiano RR. Inverted papillomas and benign non-neoplastic lesions of the nasal cavity. Am J Rhinol Allerg. 2012;26:157\u201363.","journal-title":"Am J Rhinol Allerg"},{"issue":"1","key":"3616_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MOO.0000000000000017","volume":"22","author":"S Govindaraj","year":"2014","unstructured":"Govindaraj S, Wang H. Does human papilloma virus play a role in sinonasal inverted papilloma? Curr Opin Otolaryngol Head Neck Surg. 2014;22(1):47\u201351.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"10","key":"3616_CR4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/oemed-2013-101384","volume":"70","author":"A D\u2019Errico","year":"2013","unstructured":"D\u2019Errico A, Zajacova J, Cacciatore A, Baratti A, Zanelli R, Alfonzo S, et al. Occupational risk factors for sinonasal inverted papilloma: a case-control study. Occup Environ Med. 2013;70(10):703\u20138.","journal-title":"Occup Environ Med"},{"issue":"4","key":"3616_CR5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1074\/mcp.M113.033373","volume":"13","author":"AA Mehus","year":"2014","unstructured":"Mehus AA, Muhonen WW, Garrett SH, Somji S, Sens DA, Shabb JB. Quantitation of human metallothionein isoforms: a family of small, highly conserved, cysteine-rich proteins. Mol Cell Proteomics. 2014;13(4):1020\u201333.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"3616_CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1039\/C3MT00132F","volume":"6","author":"M Raudenska","year":"2014","unstructured":"Raudenska M, Gumulec J, Podlaha O, Sztalmachova M, Babula P, Eckschlager T, et al. Metallothionein polymorphisms in pathological processes. Metallomics. 2014;6(1):55\u201368.","journal-title":"Metallomics"},{"issue":"8","key":"3616_CR7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1039\/c2mt20081c","volume":"4","author":"P Babula","year":"2012","unstructured":"Babula P, Masarik M, Adam V, Eckschlager T, Stiborova M, Trnkova L, et al. Mammalian metallothioneins: properties and functions. Metallomics. 2012;4(8):739\u201350.","journal-title":"Metallomics"},{"key":"3616_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10534-013-9696-1","volume":"27","author":"X Qiao","year":"2014","unstructured":"Qiao X, Ma ZY, Shao J, Bao WG, Xu JY, Qiang ZY, et al. Biological evaluation of a cytotoxic 2-substituted benzimidazole copper(II) complex: DNA damage, antiproliferation and apoptotic induction activity in human cervical cancer cells. Biometals. 2014;27:155\u201372.","journal-title":"Biometals"},{"issue":"14","key":"3616_CR9","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/pros.22697","volume":"73","author":"HH Juang","year":"2013","unstructured":"Juang HH, Chung LC, Sung HC, Feng TH, Lee YH, Chang PL, et al. Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells. Prostate. 2013;73(14):1495\u2013506.","journal-title":"Prostate"},{"key":"3616_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.proghi.2008.10.001","volume":"44","author":"M\u00d8 Pedersen","year":"2009","unstructured":"Pedersen M\u00d8, Larsen A, Stoltenberg M, Penkowa M. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem. 2009;44:29\u201364.","journal-title":"Prog Histochem Cytochem"},{"key":"3616_CR11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2199-14-28","volume":"14","author":"P Kling","year":"2013","unstructured":"Kling P, Modig C, Mujahed H, Khalaf H, von Hofsten J, Olsson PE. Differential regulation of the rainbow trout (Oncorhynchus mykiss) MT-A gene by nuclear factor interleukin-6 and activator protein-1. BMC Mol Biol. 2013;14:28. doi: 10.1186\/1471-2199-14-28 .","journal-title":"BMC Mol Biol"},{"key":"3616_CR12","doi-asserted-by":"crossref","first-page":"22413","DOI":"10.1074\/jbc.M114.548677","volume":"289","author":"L Chen","year":"2014","unstructured":"Chen L, Ma L, Bai Q, Zhu X, Zhang J, Wei Q, et al. Heavy metal-induced metallothionein expression is regulated by specific protein phosphatase 2A complexes. J Biol Chem. 2014;289:22413\u201326.","journal-title":"J Biol Chem"},{"issue":"8","key":"3616_CR13","doi-asserted-by":"crossref","first-page":"e105797","DOI":"10.1371\/journal.pone.0105797","volume":"9","author":"WJ Zhao","year":"2014","unstructured":"Zhao WJ, Song Q, Wang YH, Li KJ, Mao L, Hu X, et al. Zn-responsive proteome profiling and time-dependent expression of proteins regulated by MTF-1 in A549 cells. PLoS One. 2014;9(8):e105797. doi: 10.1371\/journal.pone.0105797 .","journal-title":"PLoS One"},{"issue":"3","key":"3616_CR14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3892\/ijo.2013.2223","volume":"44","author":"J Gumulec","year":"2014","unstructured":"Gumulec J, Balvan J, Sztalmachova M, Raudenska M, Dvorakova V, Knopfova L, et al. Cisplatin-resistant prostate cancer model: differences in antioxidant system, apoptosis and cell cycle. Int J Oncol. 2014;44(3):923\u201333.","journal-title":"Int J Oncol"},{"key":"3616_CR15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/1471-2407-13-462","volume":"13","author":"J Fu","year":"2013","unstructured":"Fu J, Lv H, Guan H, Ma X, Ji M, He N, et al. Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K\/Akt signaling pathway. BMC Cancer. 2013;13:462. doi: 10.1186\/1471-2407-13-462 .","journal-title":"BMC Cancer"},{"key":"3616_CR16","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1038\/cddis.2013.405","volume":"4","author":"N Habel","year":"2013","unstructured":"Habel N, Hamidouche Z, Girault I, Pati\u00f1o-Garc\u00eda A, Lecanda F, Marie PJ, et al. Zinc chelation: a metallothionein 2A\u2019s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance. Cell Death Dis. 2013;4:e874. doi: 10.1038\/cddis.2013.405 .","journal-title":"Cell Death Dis"},{"key":"3616_CR17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1479-5876-11-173","volume":"11","author":"Y Pan","year":"2013","unstructured":"Pan Y, Huang J, Xing R, Yin X, Cui J, Li W, et al. Metallothionein 2A inhibits NF-\u03baB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection. J Transl Med. 2013;11:173. doi: 10.1186\/1479-5876-11-173 .","journal-title":"J Transl Med"},{"key":"3616_CR18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12032-014-0075-8","volume":"31","author":"K Starska","year":"2014","unstructured":"Starska K, Krze\u015blak A, Forma E, Olszewski J, Lewy-Trenda I, Osuch-W\u00f3jcikiewicz E, et al. Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population. Med Oncol. 2014;31:75. doi: 10.1007\/s12032-014-0075-8 .","journal-title":"Med Oncol"},{"key":"3616_CR19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2014.08.016","volume":"280","author":"K Starska","year":"2014","unstructured":"Starska K, Kre\u015blak A, Forma E, Olszewski J, Morawiec-Sztandera A, Aleksandrowicz P, et al. The \u22125 A\/G single-nucleotide polymorphism in the core promoter region of MT2A and its effect on allele-specific gene expression and Cd, Zn and Cu levels in laryngeal cancer. Toxicol Appl Pharmacol. 2014;280:256\u201363.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"3616_CR20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10238-012-0215-4","volume":"14","author":"A Krze\u015blak","year":"2014","unstructured":"Krze\u015blak A, Forma E, J\u00f3\u017awiak P, Szymczyk A, Smolarz B, Romanowicz-Makowska H, et al. Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer. Clin Exp Med. 2014;14(1):107\u201313.","journal-title":"Clin Exp Med"},{"key":"3616_CR21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.taap.2013.02.013","volume":"268","author":"A Krze\u015blak","year":"2013","unstructured":"Krze\u015blak A, Forma E, Chwatko G, J\u00f3\u017awiak P, Szymczyk A, Wilkosz J, et al. Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer. Toxicol Appl Pharmacol. 2013;268:278\u201385.","journal-title":"Toxicol Appl Pharmacol"},{"key":"3616_CR22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cancergen.2012.05.005","volume":"205","author":"E Forma","year":"2012","unstructured":"Forma E, Krze\u015blak A, Wilkosz J, Jozwiak P, Szymczyk A, Rozanski W, et al. Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population. Cancer Genet. 2012;205:432\u20135.","journal-title":"Cancer Genet"},{"key":"3616_CR23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00439-006-0238-6","volume":"120","author":"K Kita","year":"2006","unstructured":"Kita K, Miura M, Yoshida M, Yamazaki K, Ohkubo T, Imai Y, et al. Potential effect on cellular response to cadmium of a single-nucleotide A\u2009>\u2009G polymorphism in the promoter of the human gene for metallothionein IIA. Hum Genet. 2006;120:553\u201360.","journal-title":"Hum Genet"},{"issue":"6","key":"3616_CR24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/his.12227","volume":"63","author":"MT Braz\u00e3o-Silva","year":"2013","unstructured":"Braz\u00e3o-Silva MT, Cardoso SV, de Faria PR, Dias FL, Lima RA, Eisenberg AL, et al. Adenoid cystic carcinoma of the salivary gland: a clinicopathological study of 49 cases and of metallothionein expression with regard to tumour behaviour. Histopathology. 2013;63(6):802\u20139.","journal-title":"Histopathology"},{"issue":"1","key":"3616_CR25","doi-asserted-by":"crossref","first-page":"e85346","DOI":"10.1371\/journal.pone.0085346","volume":"9","author":"J Gumulec","year":"2014","unstructured":"Gumulec J, Raudenska M, Adam V, Kizek R, Masarik M. Metallothionein - immunohistochemical cancer biomarker: a meta-analysis. PLoS One. 2014;9(1):e85346. doi: 10.1371\/journal.pone.0085346 .","journal-title":"PLoS One"},{"key":"3616_CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2559.2011.03947.x","volume":"59","author":"S Theocharis","year":"2011","unstructured":"Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, et al. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival. Histopathology. 2011;59:514\u201325.","journal-title":"Histopathology"},{"key":"3616_CR27","first-page":"335","volume":"27","author":"W Pastuszewski","year":"2007","unstructured":"Pastuszewski W, Dziegiel P, Krecicki T, Podhorska-Okolow M, Ciesielska U, Gorzynska E, et al. Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. Anticancer Res. 2007;27:335\u201342.","journal-title":"Anticancer Res"},{"key":"3616_CR28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/00005537-200006000-00015","volume":"110","author":"JH Krouse","year":"2000","unstructured":"Krouse JH. Development of a staging system for inverted papilloma. Laryngoscope. 2000;110:965\u20138.","journal-title":"Laryngoscope"},{"key":"3616_CR29","volume-title":"World Health Organization classification of tumors. pathology and genetics of head and neck tumours","author":"L Barnes","year":"2005","unstructured":"Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumors. pathology and genetics of head and neck tumours. Lyon: IARC; 2005."},{"key":"3616_CR30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7819-9-54","volume":"9","author":"N Thirumoorthy","year":"2011","unstructured":"Thirumoorthy N, Shyam Sunder A, Manisenthil Kumar K, Senthil Kumar M, Ganesh G, Chatterjee M. A review of metallothionein isoforms and their role in pathophysiology. World J Surg Oncol. 2011;9:54. doi: 10.1186\/1477-7819-9-54 .","journal-title":"World J Surg Oncol"},{"issue":"3","key":"3616_CR31","first-page":"477","volume":"35","author":"M Kanda","year":"2009","unstructured":"Kanda M, Nomoto S, Okamura Y, Nishikawa Y, Sugimoto H, Kanazumi N, et al. Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis. Int J Oncol. 2009;35(3):477\u201383.","journal-title":"Int J Oncol"},{"issue":"5","key":"3616_CR32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.breast.2013.02.008","volume":"22","author":"P Seibold","year":"2013","unstructured":"Seibold P, Hall P, Schoof N, Nevanlinna H, Heikkinen T, Benner A, et al. Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients-potential differential effects by radiotherapy? Breast. 2013;22(5):817\u201323.","journal-title":"Breast"},{"key":"3616_CR33","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/ijc.25761","volume":"129","author":"P Seibold","year":"2011","unstructured":"Seibold P, Hein R, Schmezer P, Hall P, Liu J, Dahmen N, et al. Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk. Int J Cancer. 2011;129:1467\u201376.","journal-title":"Int J Cancer"},{"key":"3616_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2011.06.023","volume":"256","author":"Z Kayaalt\u0131","year":"2011","unstructured":"Kayaalt\u0131 Z, Aliyev V, S\u00f6ylemezo\u011flu T. The potential effect of metallothionein 2A\u20135 A\/G single nucleotide polymorphism on blood cadmium, lead, zinc and copper levels. Toxicol Appl Pharmacol. 2011;256:1\u20137.","journal-title":"Toxicol Appl Pharmacol"},{"key":"3616_CR35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.taap.2010.03.007","volume":"245","author":"Z Kayaalti","year":"2010","unstructured":"Kayaalti Z, Mergen G, S\u00f6ylemezo\u011flu T. Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from a Turkish population. Toxicol Appl Pharmacol. 2010;245:252\u20135.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"3616_CR36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.archger.2011.01.001","volume":"53","author":"Z Kayaalt\u0131","year":"2011","unstructured":"Kayaalt\u0131 Z, Sahiner L, Durako\u011flugil ME, S\u00f6ylemezo\u011flu T. Distributions of interleukin-6 (IL-6) promoter and metallothionein 2A (MT2A) core promoter region gene polymorphisms and their associations with aging in Turkish population. Arch Gerontol Geriatr. 2011;53(3):354\u20138.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"3616_CR37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11033-009-9586-3","volume":"37","author":"Z Kayaalti","year":"2010","unstructured":"Kayaalti Z, S\u00f6ylemezo\u011flu T. The polymorphism of core promoter region on metallothionein 2A-metal binding protein in Turkish population. Mol Biol Rep. 2010;37(1):185\u201390.","journal-title":"Mol Biol Rep"},{"key":"3616_CR38","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/15287394.2010.485067","volume":"73","author":"JA McElroy","year":"2010","unstructured":"McElroy JA, Bryda EC, McKay SD, Schnabel RD, Taylor JF. Genetic variation at a metallothionein 2A promoter single-nucleotide polymorphism in white and black females in Midwestern United States. J Toxicol Environ Health. 2010;73:1283\u20137.","journal-title":"J Toxicol Environ Health"},{"key":"3616_CR39","author":"K Starska","year":"2015","unstructured":"Starska K, Bry\u015b M, Forma E, Olszewski J, Pietkiewicz P, Lewy-Trenda I, et al. The effect of metallothionein 2A core promoter region single-nucleotide polymorphism on accumulation of toxic metals in sinonasal inverted papilloma tissues. Toxicol Appl Pharmacol. 2015. doi: 10.1016\/j.taap.2015.04. 008 .","journal-title":"Toxicol Appl Pharmacol"},{"key":"3616_CR40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/OTT.S58044","volume":"7","author":"M Ahamed","year":"2014","unstructured":"Ahamed M, Alhadlaq HA. Nickel nanoparticle-induced dose-dependent cyto-genotoxicity in human breast carcinoma MCF-7 cells. Onco Targets Ther. 2014;7:269\u201380.","journal-title":"Onco Targets Ther"},{"key":"3616_CR41","first-page":"375","volume":"8","author":"EJ Tokar","year":"2011","unstructured":"Tokar EJ, Benbrahim-Tallaa L, Waalkes MP. Metal ions in human cancer 620 development. Met Ions Life Sci. 2011;8:375\u2013401.","journal-title":"Met Ions Life Sci"},{"key":"3616_CR42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.taap.2013.03.023","volume":"269","author":"VC Wong","year":"2013","unstructured":"Wong VC, Morse JL, Zhitkovich A. p53 activation by Ni(II) is a HIF-1\u03b1 independent response causing caspases 9\/3-mediated apoptosis in human lung cells. Toxicol Appl Pharmacol. 2013;269:233\u20139.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"3616_CR43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00420-011-0711-y","volume":"85","author":"D Tekin","year":"2012","unstructured":"Tekin D, Kayaalt\u0131 Z, S\u00f6ylemezo\u011flu T. The effects of metallothionein 2A polymorphism on lead metabolism: are pregnant women with a heterozygote genotype for metallothionein 2A polymorphism and their newborns at risk of having higher blood lead levels? Int Arch Occup Environ Health. 2012;85(6):631\u20137.","journal-title":"Int Arch Occup Environ Health"},{"key":"3616_CR44","first-page":"5255","volume":"33","author":"T Gansukh","year":"2013","unstructured":"Gansukh T, Donizy P, Halon A, Lage H, Surowiak P. In vitro analysis of the relationships between metallothionein expression and cisplatin sensitivity of non-small cellular lung cancer cells. Anticancer Res. 2013;33:5255\u201360.","journal-title":"Anticancer Res"},{"key":"3616_CR45","first-page":"567","volume":"26","author":"M Dutsch-Wicherek","year":"2005","unstructured":"Dutsch-Wicherek M, Popiela TJ, Klimek M, Rudnicka-Sosin L, Wicherek L, Oudinet JP, et al. Metallothionein stroma reaction in tumor adjacent healthy tissue in head and neck squamous cell carcinoma and breast adenocarcinoma. Neuro Endocrinol Lett. 2005;26:567\u201374.","journal-title":"Neuro Endocrinol Lett"},{"issue":"12","key":"3616_CR46","first-page":"5375","volume":"33","author":"C Kobierzycki","year":"2013","unstructured":"Kobierzycki C, Pula B, Skiba M, Jablonska K, Latkowski K, Zabel M, et al. Comparison of minichromosome maintenance proteins (MCM-3, MCM-7) and metallothioneins (MT-I\/II, MT-III) expression in relation to clinicopathological data in ovarian cancer. Anticancer Res. 2013;33(12):5375\u201383.","journal-title":"Anticancer Res"},{"key":"3616_CR47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1477-7819-11-199","volume":"11","author":"GY Liang","year":"2013","unstructured":"Liang GY, Lu SX, Xu G, Liu XD, Li J, Zhang DS. Expression of metallothionein and Nrf2 pathway genes in lung cancer and cancer-surrounding tissues. World J Surg Oncol. 2013;11:199. doi: 10.1186\/1477-7819-11-199 .","journal-title":"World J Surg Oncol"},{"issue":"1","key":"3616_CR48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yexmp.2012.10.006","volume":"94","author":"B Werynska","year":"2013","unstructured":"Werynska B, Pula B, Muszczynska-Bernhard B, Gomulkiewicz A, Piotrowska A, Prus R, et al. Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients. Exp Mol Pathol. 2013;94(1):301\u20138.","journal-title":"Exp Mol Pathol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3616-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3616-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3616-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T20:35:18Z","timestamp":1566765318000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3616-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,3]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["3616"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3616-7","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,3]]}}}